Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2026-02-22 @ 5:08 PM
Study NCT ID:
NCT01482169
Status:
COMPLETED
Last Update Posted:
2018-05-11
First Post:
2011-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR)
Sponsor:
Ochsner Health System
Organization: